ALGS vs LEN
Aligos Therapeutics Inc (ALGS) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
LEN (LEN) common stock.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
LEN does not have a complete income-statement cache yet.
ALGS currently screens at market cap $44.1M. LEN currently screens at market cap $0.
Not investment advice. Open the ALGS and LEN stock pages for the full models.
Not investment advice.